These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 7502374

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S, Maier F, Höcker P, Mayr WR, Hinterberger W.
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [Abstract] [Full Text] [Related]

  • 6. Platelet transfusion refractoriness.
    Hod E, Schwartz J.
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P, Perotti C, Noris P, Da Prada GA, Zibera C, Battaglia M, Gibelli N, Preti P, Pavesi L, Torretta L, Balduini CL, Salvaneschi L, Robustelli della Cuna G.
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet transfusion and alternatives to transfusion in patients with malignancy.
    Vaickus L, Breitmeyer JB, Schlossman RL, Anderson KC.
    Stem Cells; 1995 Nov; 13(6):588-96. PubMed ID: 8590860
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnosis and management of refractoriness to platelet transfusion.
    Schiffer CA.
    Blood Rev; 2001 Dec; 15(4):175-80. PubMed ID: 11792118
    [Abstract] [Full Text] [Related]

  • 14. Platelet transfusion therapy.
    Slichter SJ.
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):697-729, vii. PubMed ID: 17666286
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
    Federici AB, Intini D, Lattuada A, Vanelli C, Arrigoni L, Sacchi E, Russo U.
    Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
    [Abstract] [Full Text] [Related]

  • 18. A mini-review on platelet refractoriness.
    Rebulla P.
    Haematologica; 2005 Feb; 90(2):247-53. PubMed ID: 15710579
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.